Ignite Creation Date:
2024-05-05 @ 12:03 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00230217
Status:
COMPLETED
Last Update Posted:
2009-03-30
First Post:
2005-09-28
Brief Title:
Study of Rasburicase as Treatment or Prevention of Hyperuricemia Associated With Tumor Lysis Syndrome in Patients With Relapsed or Refractory Lymphoma Leukemia or Solid Tumor Malignancy
Sponsor:
Organization:
Sanofi